Kurs & Likviditet
Beskrivning
| Land | Norge |
|---|---|
| Lista | Euronext Growth Oslo |
| Sektor | Informationsteknik |
| Industri | Programvara |
2020-11-27 08:00:08
Oslo, 27 November 2020 - Today, CSAM Health Group AS (CSAM) published its
financial report for the third quarter of 2020. <br />
<br />
Report highlights include: <br />
<br />
o Q3 2020 sales of MNOK 52 367, representing growth of 4%<br />
o Q3 2020 recurring revenue of 42 903 MNOK, representing growth of 3%<br />
o Increased EBITDA margin - from 26% in Q3 2019 to 31% in Q3 2020 <br />
o Successful inaugural bond issue of 300 million NOK <br />
o Preparations to go public on the Oslo Stock Exchange, Merkur Market<br />
(Euronext Growth) in October 2020<br />
o Increased financial capacity to accelerate M&As in 2020 and beyond <br />
o YTD 2020 sales of MNOK 166 645, representing growth of 14%<br />
o YTD 2020 recurring revenue of MNOK 128 970, representing growth of 16%<br />
<br />
The full report is attached. The report can also be found on CSAM's website at
www.csamhealth.com/investor-relations. <br />
<br />
For more information, contact:<br />
<br />
Einar Bonnevie<br />
Chief Financial Officer<br />
+47 91 55 45 32<br />
einar.bonnevie@csamhealth.com<br />
<br />
About CSAM<br />
<br />
CSAM has established itself as a leading Nordic niche player in the specialised
eHealth market with a unique blend of best-in-class innovative technology, and
outstanding human skills. The company's diverse portfolio of software solutions
enables healthcare providers to access relevant clinical information at the
point of care. CSAM's commercial headquarters are located in Oslo, Norway. The
company also has local offices in Stockholm, Karlstad, Gothenburg, Copenhagen,
Helsinki, Oulu, Tampere, Tromsø and Warwickshire, as well as a wholly owned
software engineering subsidiary in the Philippines.<br />
<br />
For more information, visit www.csamhealth.com.